Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

New Hybrid Benzothiazole Derivatives from Gallic and Syringic Acid as a Potential Multifunctional Skin Disease.

Molecules (Basel, Switzerland)·2026

Same author

Bio-Oss<sup>®</sup>/Avitene™ composite scaffold promotes maxillofacial bone regeneration via early osteoimmunomodulation of BM-MSCs: an <i>in vitro</i> and clinical study.

Frontiers in bioengineering and biotechnology·2026

Same author

Diving into AA9-mediated transglutaminase 2 inhibition reveals ferroptosis as driver of anticancer effects.

Biochemical pharmacology·2026

Same author

Reduced cyclin D3 expression in erythroid cells protects against malaria.

Nature·2026

Same author

Modulation of immune responses by elexacaftor/tezacaftor/ivacaftor therapy in cystic fibrosis: data from a compassionate use program.

Respiratory research·2026

Same author

GY971 mitigates inflammation by reducing neutrophil recruitment in cystic fibrosis Ex Vivo and In Vivo models.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2025

Search research articles

Related Experiment Video

Updated: Mar 15, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

A validated cellular biobank for β-thalassemia.

Lucia Carmela Cosenza¹, Laura Breda^2,3, Giulia Breveglieri⁴

¹Department of Life Sciences and Biotechnology, Section of Biochemistry and Molecular Biology, University of Ferrara, Via Fossato di Mortara 74, 44121, Ferrara, Italy.

Journal of Translational Medicine

|September 4, 2016

Summary

A new biobank of expanded erythroid precursor cells from beta-thalassemia patients was created and validated. This resource enables patient stratification and reproducible testing of fetal hemoglobin inducers and gene therapies.

Keywords:

Biobanking Gene therapy HbF induction Thalassemia

More Related Videos

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Establishment of a Clinic-based Biorepository

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

Related Experiment Videos

Last Updated: Mar 15, 2026

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies

Published on: September 6, 2017

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management

Published on: November 30, 2022

Establishment of a Clinic-based Biorepository

Establishment of a Clinic-based Biorepository

Published on: May 29, 2017

Area of Science:

Biomedical research
Cellular biobanking
Hematology

Background:

Cellular biobanking is crucial for collaborative research networks.
It is particularly important for beta-thalassemia studies where patient recruitment and sample collection are challenging.
This study focuses on creating a specialized biobank for beta-thalassemia research.

Purpose of the Study:

To establish and validate a biobank of expanded erythroid precursor cells from beta-thalassemia patients.
To ensure the reliability and reproducibility of biobanked samples for research.

Main Methods:

Obtained and expanded erythroid precursor cells from 72 patients, primarily with beta-thalassemia.
Cryopreserved cells and validated their phenotype through multiple sample collections, freezing, and thawing cycles.
Assessed gene expression (RT-qPCR) and hemoglobin production (HPLC).
Confirmed reproducibility by shipping cells to different labs for standardized analysis.

Main Results:

Successfully produced and validated the Thal-Biobank with expanded erythroid precursor cells.
Demonstrated phenotype maintenance across independent collections, cryopreservation, and thawing.
Confirmed inter-laboratory reproducibility using standardized protocols.
Stratified biobanked cells based on fetal hemoglobin levels for further experiments.

Conclusions:

The Thal-Biobank provides a reliable resource for beta-thalassemia research.
Biobanked cells allow for patient stratification based on fetal hemoglobin production.
This resource facilitates reproducible assessment of fetal hemoglobin inducers (e.g., hydroxyurea) and gene therapy efficacy.